Trimethoxyamphetamine

From Wikipedia, the free encyclopedia

TMAs, also known as trimethoxyamphetamines, are a family of isomeric psychedelic hallucinogenic drugs. There exist six different TMAs that differ only in the position of the three methoxy groups: TMA, TMA-2, TMA-3, TMA-4, TMA-5, and TMA-6. The TMAs are analogs of the phenethylamine cactus alkaloid mescaline. The TMAs are substituted amphetamines, however, their action does not resemble that of the unsubstituted compound amphetamine, which is a stimulant and not a psychedelic. It is reported that some TMA's elicit a range of emotions ranging from sadness to empathy and euphoria. They were first synthesized by the chemist Alexander Shulgin. Synthesis data as well as human activity data has been published in the book PiHKAL (Phenethylamines i Have Known And Loved).

The most important TMA compound from a pharmacological standpoint is TMA-2, as this isomer has been much more widely used as a recreational drug and sold on the grey market as a so called "research chemical"; TMA (sometimes referred to as "mescalamphetamine" or TMA-1) and TMA-6 have also been used in this way to a lesser extent. These three isomers are significantly more active as hallucinogenic drugs, and have consequently been placed onto the illegal drug schedules in some countries such as the Netherlands and Japan. The other three isomers TMA-3, TMA-4 and TMA-5 are not known to have been used as recreational drugs to any great extent, and remain obscure scientific curiosities.

TMAs


Note: As they are isomers the TMAs have the same totals formula, C12H19NO3, and the same molecular mass, 225.28 g/mol.

Properties

Compound Pattern Dose Duration
TMA 3,4,5 100 – 250 mg 6 - 8 h
TMA-2 2,4,5 20 – 40 mg 8 - 12 h
TMA-3 2,3,4 > 100 mg unknown
TMA-4 2,3,5 > 80 mg ~ 6 h
TMA-5 2,3,6 ≥ 30 mg 8 - 10 h
TMA-6 2,4,6 25 – 50 mg 12 - 16 h

Legality

Sweden

Sveriges riksdag added TMA-2 to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Dec 30, 1999, published by Medical Products Agency in their regulation LVFS 2004:3 listed as 2,4,5-trimetoxiamfetamin (TMA-2).[1]

See also

References

  1. ^ http://www.lakemedelsverket.se/upload/lvfs/LVFS_2004-3.pdf

External links

  • PiHKAL entries:
    • TMA
    • TMA in PiHKAL • info
    • TMA-2
    • TMA-2 in PiHKAL • info
    • TMA-3
    • TMA-3 in PiHKAL • info
    • TMA-4
    • TMA-4 in PiHKAL • info
    • TMA-5
    • TMA-5 in PiHKAL • info
    • TMA-6
    • TMA-6 in PiHKAL • info
  • Erowid TMA vault
  • EMCDDA Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs
Retrieved from "https://en.wikipedia.org/w/index.php?title=Trimethoxyamphetamine&oldid=835764104"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Trimethoxyamphetamine
This page is based on the copyrighted Wikipedia article "Trimethoxyamphetamine"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA